Afuco™ Anti-Human CEACAM1 ADCC Therapeutic Antibody (CM-24), ADCC Enhanced
Anti-CEACAM1 ADCC Enhanced Antibody (CM-24) is an ADCC enhanced antibody produced by our Afuco™ platform. CM-24 is a Phase 1, first-in-class humanized anti CEACAM1 monoclonal antibody that inhibits the immunosuppressive effect of CEAC AM1, leading to an enhanced anti-tumor immune response of T and NK cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-147CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CEACAM1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |